文献速递妇科生殖医学

青少年和年轻子宫内膜异位症患者疼痛亚型的血浆蛋白质组学特征

Plasma proteomic profiles of pain subtypes in adolescents and young adults with endometriosis.
PubMed 文献 · Hum Reprod · 2023-01-01

本研究对142名经腹腔镜确诊子宫内膜异位症的青少年或年轻成人进行横断面分析,用SomaScan检测1305种血浆蛋白。结果显示不同疼痛亚型具有不同的血浆蛋白质组谱,提示不同疼痛亚型可能涉及不同的分子机制。

要点

  • 子宫内膜异位症相关疼痛亚型表现出不同的血浆蛋白质组谱。
  • 严重痛经和生活影响性盆腔痛患者多个细胞运动通路下调。
  • 不同疼痛亚型涉及不同的免疫通路改变,提示疼痛亚型需考虑不同机制。

核心结论

  • 子宫内膜异位症相关疼痛亚型表现出不同的血浆蛋白质组谱,提示不同疼痛亚型可能涉及不同的分子机制。
  • 作者认为需要考虑疼痛亚型以有效治疗表现为各种疼痛症状的子宫内膜异位症患者。

研究设计与样本

  • 横断面分析,使用来自女性健康研究:从青春期到成年队列的142名经腹腔镜确诊子宫内膜异位症的青少年或年轻成人参与者的数据和血浆样本。
  • 通过SomaScan测量1305种血浆蛋白水平。
  • 将自我报告的子宫内膜异位症相关疼痛分类为痛经、非周期性盆腔痛、生活影响性盆腔痛、膀胱痛、肠道痛和广泛性疼痛表型等亚型。
  • 使用逻辑回归计算差异表达蛋白的比值比和95%置信区间,调整采血时年龄、BMI、空腹状态和激素使用。
  • 使用Ingenuity Pathway Analysis识别富集的生物学通路。

主要发现

  • 研究人群主要为青少年和年轻成人(采血时平均年龄=18岁),几乎所有(97%)在腹腔镜诊断时评分为rASRM I/II期。
  • 与无严重痛经和生活影响性盆腔痛者相比,有严重痛经和生活影响性盆腔痛者多个细胞运动通路下调(P < 7.5×10-15)。
  • 与非周期性盆腔痛者相比,有非周期性盆腔痛者免疫细胞黏附通路上调(P < 9.0×10-9)。
  • 与无膀胱痛者相比,有膀胱痛者免疫细胞迁移通路上调(P < 3.7×10-8);与无肠道痛者相比,有肠道痛者免疫细胞迁移通路下调(P < 6.5×10-7)。
  • 有广泛性疼痛表型涉及多个免疫通路下调(P < 8.0×10-10)。

局限性

  • 研究缺乏独立验证队列。
  • 仅能探索疼痛亚型的存在,无法评估疼痛亚型的多种组合。
  • 需要进一步机制研究以阐明子宫内膜异位症疼痛亚型的病理生理差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are the similarities and differences in the systemic proteomic profiles by endometriosis-associated pain subtypes among adolescents and young adults with endometriosis? SUMMARY ANSWER: Endometriosis-associated pain subtypes exhibited distinct plasma proteomic profiles. WHAT IS KNOWN ALREADY: Endometriosis patients, especially those diagnosed in adolescents and young adults, are often plagued by various pain symptoms. However, it is not clear what biological processes underlie this heterogeneity. STUDY DESIGN, SIZE, DURATION: We conducted a cross-sectional analysis using data and plasma samples from 142 adolescent or young adult participants of the Women's Health Study: From Adolescence to Adulthood cohort with laparoscopically confirmed endometriosis. PARTICIPANTS/MATERIALS, SETTING, METHODS: We measured 1305 plasma protein levels by SomaScan. We classified self-reported endometriosis-associated pain into subtypes of dysmenorrhea, acyclic pelvic pain, life impacting pelvic pain, bladder pain, bowel pain, and widespread pain phenotype. We used logistic regression to calculate the odds ratios and 95% confidence intervals for differentially expressed proteins, adjusting for age, BMI, fasting status, and hormone use at blood draw. Ingenuity Pathway Analysis identified enriched biological pathways. MAIN RESULTS AND THE ROLE OF CHANCE: Our study population consisted mainly of adolescents and young adults (mean age at blood draw = 18 years), with nearly all (97%) scored as rASRM stage I/II at laparoscopic diagnosis of endometriosis, which is a common clinical presentation of endometriosis diagnosed at a younger age. Pain subtypes exhibited distinct plasma proteomic profiles. Multiple cell movement pathways were downregulated in cases with severe dysmenorrhea and life impacting pelvic pain compared to those without (P < 7.5×10-15). Endometriosis cases with acyclic pelvic pain had upregulation of immune cell adhesion pathways (P < 9.0×10-9), while those with bladder pain had upregulation of immune cell migration (P < 3.7×10-8) and those with bowel pain had downregulation (P < 6.5×10-7) of the immune cell migration pathways compared to those without. Having a wide-spread pain phenotype involved downregulation of multiple immune pathways (P < 8.0×10-10). LIMITATIONS, REASONS FOR CAUTION: Our study was limited by the lack of an independent validation cohort. We were also only able to explore any presence of a pain subtype and could not evaluate multiple combinations by pain subtypes. Further mechanistic studies are warranted to elucidate the differences in pathophysiology by endometriosis-pain subtype. WIDER IMPLICATIONS OF THE FINDINGS: The observed variation in plasma protein profiles by pain subtypes suggests different underlying molecular mechanisms, highlighting the need for potential consideration of pain subtypes for effectively treating endometriosis patients presenting with various pain symptoms. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Department of Defense W81XWH1910318 and the 2017 Boston Center for Endometriosis Trainee Award. Financial support for establishment of and data collection within the A2A cohort were provided by the J. Willard and Alice S. Marriott Foundation. N.S., A.F.V., S.A.M., and K.L.T. have received funding from the Marriott Family Foundation. C.B.S. is funded by an R35 MIRA Award from NIGMS (5R35GM142676). S.A.M. and K.L.T. are supported by NICHD R01HD094842. S.A.M. reports serving as an advisory board member for AbbVie and Roche, Field Chief Editor for Frontiers in Reproductive Health, personal fees from Abbott for roundtable participation; none of these are related to this study. Other authors report no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Sasamoto N, Ngo L, Vitonis AF, et al. Plasma proteomic profiles of pain subtypes in adolescents and young adults with endometriosis. Hum Reprod. 2023. PMID: 37196326. doi:10.1093/humrep/dead099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。